Published in Nat Genet on October 01, 1995
The microglial sensome revealed by direct RNA sequencing. Nat Neurosci (2013) 2.73
Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci U S A (2000) 2.11
ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection. Cell Microbiol (2008) 2.01
A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest (1999) 1.96
Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients. J Biol Chem (2004) 1.88
Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci U S A (1999) 1.79
Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis. J Mol Biol (2006) 1.59
Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. J Clin Invest (1998) 1.59
Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1999) 1.53
Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J Clin Invest (1998) 1.49
Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci U S A (2004) 1.48
Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc Natl Acad Sci U S A (1996) 1.44
Ganglioside/glycosphingolipid turnover: new concepts. Glycoconj J (2004) 1.39
Lysosomal lipid storage diseases. Cold Spring Harb Perspect Biol (2011) 1.26
Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure. Proc Natl Acad Sci U S A (1998) 1.23
Multi-system disorders of glycosphingolipid and ganglioside metabolism. J Lipid Res (2010) 1.22
Criteria for validating mouse models of psychiatric diseases. Am J Med Genet B Neuropsychiatr Genet (2009) 1.21
Effective gene therapy in an authentic model of Tay-Sachs-related diseases. Proc Natl Acad Sci U S A (2006) 1.18
ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Proc Natl Acad Sci U S A (2013) 1.18
Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1. Carbohydr Res (2006) 1.11
Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy. J Inherit Metab Dis (2001) 1.11
RIPK3 as a potential therapeutic target for Gaucher's disease. Nat Med (2014) 1.08
Role for lysosomal enzyme beta-hexosaminidase in the control of mycobacteria infection. Proc Natl Acad Sci U S A (2008) 1.08
Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system. Proc Natl Acad Sci U S A (1997) 1.06
Transgenic nonhuman primates for neurodegenerative diseases. Reprod Biol Endocrinol (2004) 1.06
E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment. J Biol Chem (2011) 1.03
Macroautophagy is not directly involved in the metabolism of amyloid precursor protein. J Biol Chem (2010) 1.03
Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis. Chem Biol (2010) 1.03
Substrate reduction therapy in mouse models of the glycosphingolipidoses. Philos Trans R Soc Lond B Biol Sci (2003) 1.00
Gene transfer corrects acute GM2 gangliosidosis--potential therapeutic contribution of perivascular enzyme flow. Mol Ther (2012) 0.97
Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment. Proc Natl Acad Sci U S A (1997) 0.96
Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders. Int J Mol Sci (2016) 0.94
Beta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis. Glycoconj J (1997) 0.93
Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease. PLoS One (2011) 0.92
Animal models for metabolic, neuromuscular and ophthalmological rare diseases. Nat Rev Drug Discov (2013) 0.92
Peripheral blood mononuclear cell infiltration and neuroinflammation in the HexB-/- mouse model of neurodegeneration. J Neuroimmunol (2008) 0.91
Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates. Mol Ther (2014) 0.90
Early deficits in motor coordination and cognitive dysfunction in a mouse model of the neurodegenerative lysosomal storage disorder, Sandhoff disease. Behav Brain Res (2008) 0.90
Reversibility of neuropathology in Tay-Sachs-related diseases. Hum Mol Genet (2013) 0.89
Ganglioside biochemistry. ISRN Biochem (2012) 0.89
Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease. Exp Neurol (2014) 0.89
Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders. J Inherit Metab Dis (2010) 0.89
Glycosphingolipidoses: beyond the enzymatic defect. Glycoconj J (2004) 0.89
Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease. Lipids (2008) 0.88
DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice. J Clin Invest (2009) 0.88
Podocyte pathology and nephropathy - sphingolipids in glomerular diseases. Front Endocrinol (Lausanne) (2014) 0.87
Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses. J Clin Invest (2004) 0.87
Mice doubly-deficient in lysosomal hexosaminidase A and neuraminidase 4 show epileptic crises and rapid neuronal loss. PLoS Genet (2010) 0.87
Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease. Stem Cells (2009) 0.86
Glycosphingolipid degradation and animal models of GM2-gangliosidoses. J Inherit Metab Dis (1998) 0.85
Preparation and electrophoretic separation of Bodipy-Fl-labeled glycosphingolipids. J Chromatogr A (2012) 0.85
Capillary electrophoresis with three-color fluorescence detection for the analysis of glycosphingolipid metabolism. Analyst (2012) 0.84
A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism. Genes Brain Behav (2012) 0.84
Thymic alterations in GM2 gangliosidoses model mice. PLoS One (2010) 0.83
Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration. PLoS One (2011) 0.83
Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies. Brain (2014) 0.83
Sphingolipids and membrane biology as determined from genetic models. Prostaglandins Other Lipid Mediat (2007) 0.81
Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells. Glycoconj J (2010) 0.81
Conditional expression of human β-hexosaminidase in the neurons of Sandhoff disease rescues mice from neurodegeneration but not neuroinflammation. J Neuroinflammation (2012) 0.81
Impaired neural differentiation of induced pluripotent stem cells generated from a mouse model of Sandhoff disease. PLoS One (2013) 0.81
A novel instrumented multipeg running wheel system, Step-Wheel, for monitoring and controlling complex sequential stepping in mice. J Neurophysiol (2011) 0.80
Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice. J Inherit Metab Dis (2010) 0.80
In cellulo examination of a beta-alpha hybrid construct of beta-hexosaminidase A subunits, reported to interact with the GM2 activator protein and hydrolyze GM2 ganglioside. PLoS One (2013) 0.80
Early changes in the apparent diffusion coefficient (ADC) in a mouse model of Sandhoff's disease occur prior to disease symptoms and behavioral deficits. Magn Reson Med (2009) 0.79
Peripheral nervous system manifestations in a Sandhoff disease mouse model: nerve conduction, myelin structure, lipid analysis. J Negat Results Biomed (2007) 0.79
Elevation of lung surfactant phosphatidylcholine in mouse models of Sandhoff and of Niemann-Pick A disease. J Inherit Metab Dis (2004) 0.79
Prostaglandin E2 reverses aberrant production of an inflammatory chemokine by microglia from Sandhoff disease model mice through the cAMP-PKA pathway. PLoS One (2011) 0.79
Degradation of G(M1) and G(M2) by mammalian sialidases. Biochem J (2001) 0.79
Circadian profiling in two mouse models of lysosomal storage disorders; Niemann Pick type-C and Sandhoff disease. Behav Brain Res (2015) 0.78
Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses. J Lipid Res (2015) 0.78
Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model. PLoS One (2014) 0.77
Manipulating ionic strength to improve single cell electrophoretic separations. Talanta (2013) 0.77
Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy. Mol Genet Metab (2012) 0.77
Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model. J Clin Invest (2016) 0.77
Construction of a hybrid β-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo. Mol Ther Methods Clin Dev (2016) 0.77
Characterization of inducible models of Tay-Sachs and related disease. PLoS Genet (2012) 0.76
Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease. Hum Gene Ther (2016) 0.76
Induction of the type I interferon response in neurological forms of Gaucher disease. J Neuroinflammation (2016) 0.76
TSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology. Neurobiol Dis (2015) 0.76
Altered behavioral development in Nrf2 knockout mice following early postnatal exposure to valproic acid. Brain Res Bull (2014) 0.76
Animal models of GM2 gangliosidosis: utility and limitations. Appl Clin Genet (2016) 0.75
Supply-side and trickle-down therapy. J Clin Invest (1999) 0.75
FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice. Sci Rep (2017) 0.75
Neuraminidase-1 contributes significantly to the degradation of neuronal B-series gangliosides but not to the bypass of the catabolic block in Tay-Sachs mouse models. Mol Genet Metab Rep (2015) 0.75
Enhancement by Uridine Diphosphate of Macrophage Inflammatory Protein-1 Alpha Production in Microglia Derived from Sandhoff Disease Model Mice. JIMD Rep (2015) 0.75
AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease. Neuroscience (2016) 0.75
Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration. Genes Brain Behav (2017) 0.75
Structural organization and expression of the gene for the mouse GM2 activator protein. Mamm Genome (1997) 0.75
Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol (2001) 13.98
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A (1996) 12.92
Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature (1996) 11.46
Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell (1996) 10.40
Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A (1992) 9.19
The integrated state of viral DNA in SV40-transformed cells. Proc Natl Acad Sci U S A (1968) 8.38
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol (1995) 7.12
Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity (1995) 7.08
Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology (2007) 6.61
The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J (1997) 6.36
A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother (1995) 6.00
Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis (1997) 5.81
Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci U S A (1980) 5.55
Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest (2000) 5.48
Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science (2000) 5.44
Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav (2004) 5.15
Crystal structure of TFIID TATA-box binding protein. Nature (1992) 4.85
Quantitative assessment of DNA microarrays--comparison with Northern blot analyses. Genomics (2001) 4.56
Viral DNA in polyoma- and SV40-transformed cell lines. Proc Natl Acad Sci U S A (1968) 4.24
The Drosophila mushroom body is a quadruple structure of clonal units each of which contains a virtually identical set of neurones and glial cells. Development (1997) 4.14
A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature (1998) 4.06
Essential role of LAT in T cell development. Immunity (1999) 3.94
Defects in enteric innervation and kidney development in mice lacking GDNF. Nature (1996) 3.82
CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med (1998) 3.82
SV40 DNA strand selection by Escherichia coli RNA polymerase. J Mol Biol (1970) 3.77
Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav (2007) 3.76
Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav (2004) 3.69
Essential role for Sonic hedgehog during hair follicle morphogenesis. Dev Biol (1999) 3.62
Formation and reversion of Streptomycete protoplasts: cultural condition and morphological study. J Gen Microbiol (1974) 3.56
Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res (2001) 3.51
Sonic hedgehog is essential to foregut development. Nat Genet (1998) 3.50
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci (2001) 3.50
Molecular structure of a gene, VMA1, encoding the catalytic subunit of H(+)-translocating adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae. J Biol Chem (1990) 3.47
Autophagosome requires specific early Sec proteins for its formation and NSF/SNARE for vacuolar fusion. Mol Biol Cell (2001) 3.41
Oncogenesis of the lens in transgenic mice. Science (1987) 3.40
Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet (1996) 3.40
Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol (1998) 3.34
Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev Cell (2001) 3.30
Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci U S A (1997) 3.27
Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol (1999) 3.18
Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell (1997) 3.10
The Rx homeobox gene is essential for vertebrate eye development. Nature (1997) 3.08
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology (1999) 3.00
Spliced adenovirus-associated virus RNA. Proc Natl Acad Sci U S A (1979) 2.99
Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci U S A (2001) 2.97
Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J Exp Med (2001) 2.96
Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol (1998) 2.94
Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol (1975) 2.86
Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem (1996) 2.85
Phylogenetic analysis of the coryneform bacteria by 5S rRNA sequences. J Bacteriol (1987) 2.83
Molecular cloning and sequence determination of cDNAs for alpha subunits of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain. Proc Natl Acad Sci U S A (1986) 2.83
Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med (1998) 2.80
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med (1997) 2.79
Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet (2001) 2.76
The structure of adenovirus 2 early nuclear and cytoplasmic RNAs. J Mol Biol (1980) 2.74
Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene. Proc Natl Acad Sci U S A (1998) 2.71
E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA. Mol Cell Biol (1985) 2.68
Xenopus M phase MAP kinase: isolation of its cDNA and activation by MPF. EMBO J (1991) 2.68
Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet (1995) 2.66
Lhx2, a LIM homeobox gene, is required for eye, forebrain, and definitive erythrocyte development. Development (1997) 2.66
Functions of LIM-homeobox genes. Trends Genet (2000) 2.66
Requirement of CD9 on the egg plasma membrane for fertilization. Science (2000) 2.65
Structure and physiological function of calpains. Biochem J (1997) 2.62
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62
Loop structures in hybrids of early RNA and the separated strands of adenovirus DNA. Proc Natl Acad Sci U S A (1977) 2.60
Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem (1983) 2.58
Structural similarity between TAFs and the heterotetrameric core of the histone octamer. Nature (1996) 2.58
Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. Nature (1996) 2.57
Unique TATA-binding protein-containing complexes and cofactors involved in transcription by RNA polymerases II and III. EMBO J (1993) 2.56
Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell (1996) 2.53
Evolutionary origin of a calcium-dependent protease by fusion of genes for a thiol protease and a calcium-binding protein? Nature (1985) 2.52
Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol (2003) 2.52
LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons. Cell (1998) 2.50
Volatile anaesthetics and the atmosphere: atmospheric lifetimes and atmospheric effects of halothane, enflurane, isoflurane, desflurane and sevoflurane. Br J Anaesth (1999) 2.49
Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci U S A (1970) 2.48
CD95 signaling via ceramide-rich membrane rafts. J Biol Chem (2001) 2.48
Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature (1997) 2.46
Mitotic regulation of TFIID: inhibition of activator-dependent transcription and changes in subcellular localization. Genes Dev (1996) 2.45
A novel phorbol ester receptor/protein kinase, nPKC, distantly related to the protein kinase C family. Cell (1988) 2.44
Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen. Infect Immun (1974) 2.43
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. J Pharmacol Exp Ther (2004) 2.42
Membrane receptors for bacterial toxins. Microbiol Rev (1983) 2.41
Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev (1985) 2.40
Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature (2001) 2.39
Gene cloning of chitinase A1 from Bacillus circulans WL-12 revealed its evolutionary relationship to Serratia chitinase and to the type III homology units of fibronectin. J Biol Chem (1990) 2.38
Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun (1999) 2.38
Blood clearance rates of adenovirus type 5 in mice. J Gen Virol (2000) 2.36
Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc Natl Acad Sci U S A (2000) 2.36
Nonmuscle myosin II-B is required for normal development of the mouse heart. Proc Natl Acad Sci U S A (1997) 2.35
Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat Immunol (2001) 2.34
A cascade of adenovirus early functions is required for expression of adeno-associated virus. Cell (1981) 2.33
Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J (1994) 2.33
Comparative study on adhesive performance of functional monomers. J Dent Res (2004) 2.32